Jounce Therapeutics Inc (JNCE) Insider Trading
- $10,187,139.99
- $24,080,437.29
- April 4, 2023
- Kimberlee C Drapkin
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 1, 2017 | Major Shareholder | 625,000 | $16.00 | Buy | $10,000,000.00 | |
| Feb. 1, 2017 | Director | 6,700 | $16.00 | Buy | $107,200.00 |
Insiders are both buying and selling Jounce Therapeutics Inc stock.
The insider traders at Jounce Therapeutics Inc are: Kimberlee C Drapkin, Richard /Ca/ Murray, Elizabeth Trehu, Hugh M Cole, John Duncan Higgons, Barbara Gayle Duncan, Rock Ventures Ii L.P. Third, Celgene Switzerland Llc, Rock Ventures Iii L.P. Third, and Kevin C Tang
The most active insider trader at Jounce Therapeutics Inc is Kimberlee C Drapkin with 12 trades.
Rock Ventures Iii L.P. Third has sold the most Jounce Therapeutics Inc stock with a total value of $31,844,000.00.
Celgene Switzerland Llc has bought the most Jounce Therapeutics Inc stock with a total value of $20,000,000.00.
The most recent insider trade for Jounce Therapeutics Inc was on April 4, 2023.
The single biggest insider buy for Jounce Therapeutics Inc was from Celgene Switzerland Llc with a total value of $10,000,000.00 on Feb. 1, 2017.
The single biggest insider sell for Jounce Therapeutics Inc was from Rock Ventures Iii L.P. Third with a total value of $15,922,000.00 on Nov. 12, 2021.